glp-1 logo Glucagon-like Peptide (GLP-1) - Diabetes Treatment GLP-1 Hub Store
Description
These delays highlight the structural barriers that can slow adoption in populations with higher rates of comorbidities
Always great reporting and enjoyed contributing to this article from The New York Times and Dani Blum on the evolution of the GLP-1 market, specifically the growth of grey and illicit markets online
Termszetes hormonlis egyensly s anyagcsere-tmogats
Here's what's behind changes to your monthly flow on this Rx
And that might lead to some problems for patients and insurers
See side effects, costs...
